AstraZeneca PLC (AZNCF)
130.24
+1.04
(+0.80%)
USD |
OTCM |
Nov 14, 16:00
AstraZeneca Market Cap: 201.91B for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 14, 2024 | 201.91B |
| November 13, 2024 | 200.29B |
| November 12, 2024 | 199.08B |
| November 11, 2024 | 196.57B |
| November 08, 2024 | 198.03B |
| November 07, 2024 | 196.19B |
| November 06, 2024 | 196.17B |
| November 05, 2024 | 203.15B |
| November 04, 2024 | 220.81B |
| November 01, 2024 | 221.46B |
| October 31, 2024 | 219.98B |
| October 30, 2024 | 231.77B |
| October 29, 2024 | 232.00B |
| October 28, 2024 | 230.37B |
| October 25, 2024 | 230.37B |
| October 24, 2024 | 235.18B |
| October 23, 2024 | 236.16B |
| October 22, 2024 | 242.46B |
| October 21, 2024 | 239.73B |
| October 18, 2024 | 244.76B |
| October 17, 2024 | 239.55B |
| October 16, 2024 | 238.28B |
| October 15, 2024 | 238.28B |
| October 14, 2024 | 228.46B |
| October 11, 2024 | 228.46B |
| Date | Value |
|---|---|
| October 10, 2024 | 228.46B |
| October 09, 2024 | 230.45B |
| October 08, 2024 | 230.45B |
| October 07, 2024 | 241.41B |
| October 04, 2024 | 236.66B |
| October 03, 2024 | 236.88B |
| October 02, 2024 | 246.40B |
| October 01, 2024 | 241.10B |
| September 30, 2024 | 239.45B |
| September 27, 2024 | 239.45B |
| September 26, 2024 | 237.66B |
| September 25, 2024 | 237.66B |
| September 24, 2024 | 231.52B |
| September 23, 2024 | 240.51B |
| September 20, 2024 | 240.51B |
| September 19, 2024 | 244.53B |
| September 18, 2024 | 254.20B |
| September 17, 2024 | 244.63B |
| September 16, 2024 | 243.39B |
| September 13, 2024 | 245.16B |
| September 12, 2024 | 242.43B |
| September 11, 2024 | 248.41B |
| September 10, 2024 | 248.41B |
| September 09, 2024 | 248.17B |
| September 06, 2024 | 261.96B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
99.73B
Minimum
Mar 13 2020
271.30B
Maximum
Aug 30 2024
182.99B
Average
190.34B
Median
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 151.20M |
| Biodexa Pharmaceuticals PLC | 2.823M |
| Verona Pharma PLC | 2.894B |
| NuCana PLC | 3.482M |
| Autolus Therapeutics PLC | 800.94M |
Market Cap Related Metrics
| PE Ratio | 31.46 |
| PS Ratio | 4.140 |
| PEG Ratio | 6.921 |
| Price to Book Value | 5.110 |
| Price to Free Cash Flow | 29.20 |
| Price | 130.24 |
| Earnings Yield | 3.18% |
| PEGY Ratio | 4.604 |
| Operating PE Ratio | 20.72 |
| Normalized PE Ratio | 28.83 |